Mobile teledermoscopy for patients at high risk of cutaneous melanoma: A single-arm, feasibility study of a clinical intervention at two tertiary centres (MOBILEMEL)

被引：0
|
作者：
Martin, Arthur [1 ]
Cust, Anne [2 ]
Lo, Serigne [3 ]
Morton, Rachael [4 ]
Kasparian, Nadine [5 ]
Teh, Natalie [6 ]
Collgros, Helena [7 ,8 ]
Martin, Linda [9 ]
Guitera, Pascale [10 ]
机构：
[1] Melanoma Inst Australia, Wollstonecraft, NSW, Australia
[2] Univ Sydney, Melanoma Inst Australia, Joint Venture Canc Council, Daffodil Ctr, Sydney, NSW, Australia
[3] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[4] Univ Sydney, Camperdown, NSW, Australia
[5] Univ New South Wales, Sydney, NSW, Australia
[6] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[7] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[8] Royal Prince Alfred Hosp, Sydney Melanoma Diagnost Ctr, Sydney, NSW, Australia
[9] Melanoma Inst Australia, Sydney, NSW, Australia
[10] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [41] Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning
    Liu Shi-Meng
    Zhao Wen-Le
    Song Hai-Qing
    Meng Ran
    Li Si-Jie
    Ren Chang-Hong
    Ovbiagele Bruce
    Ji Xun-Ming
    Feng Wu-Wei
    中华医学杂志英文版, 2018, 131 (03) : 347 - 351
  • [42] A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes
    Caponnetto, Pasquale
    DiPiazza, Jennifer
    Kim, Jason
    Maglia, Marilena
    Polosa, Riccardo
    NICOTINE & TOBACCO RESEARCH, 2021, 23 (07) : 1113 - 1122
  • [43] Phase III, single-arm study investigating the efficacy, safety, and tolerability of anagrelide as a second-line treatment in high-risk Japanese patients with essential thrombocythemia
    Kanakura, Yuzuru
    Miyakawa, Yoshitaka
    Wilde, Paul
    Smith, Jonathan
    Achenbach, Heinrich
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (04) : 353 - 360
  • [44] Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study
    Liu, Shimeng
    Gao, Zongen
    Meng, Ran
    Song, Haiqing
    Tang, Tianping
    Zhao, Ya
    Chen, Rong
    Sheng, Yanzhen
    Fan, Qianqian
    Jiang, Fang
    Zhang, Qian
    Ding, Jianping
    Huang, Xiaoqin
    Ma, Qingfeng
    Dong, Kai
    Xue, Sufang
    Yu, Zhipeng
    Duan, Jiangang
    Chu, Changbiao
    Chen, Xiaohui
    Huang, Xingquan
    Li, Sijie
    Ovbiagele, Bruce
    Zhao, Wenle
    Ji, Xunming
    Feng, Wuwei
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [45] Phase III, single-arm study investigating the efficacy, safety, and tolerability of anagrelide as a second-line treatment in high-risk Japanese patients with essential thrombocythemia
    Yuzuru Kanakura
    Yoshitaka Miyakawa
    Paul Wilde
    Jonathan Smith
    Heinrich Achenbach
    Shinichiro Okamoto
    International Journal of Hematology, 2014, 100 : 353 - 360
  • [46] A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)
    Oashi, Kohei
    Shibata, Taro
    Namikawa, Kenjiro
    Takahashi, Akira
    Yokota, Kenji
    Nakano, Eiji
    Teramoto, Yukiko
    Tsutsumida, Arata
    Maeda, Taku
    Yamazaki, Naoya
    BMC CANCER, 2020, 20 (01)
  • [47] A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)
    Kohei Oashi
    Taro Shibata
    Kenjiro Namikawa
    Akira Takahashi
    Kenji Yokota
    Eiji Nakano
    Yukiko Teramoto
    Arata Tsutsumida
    Taku Maeda
    Naoya Yamazaki
    BMC Cancer, 20
  • [48] Protocol for a single-arm confirmatory trial of adjuvant chemoradiation for patients with high-risk rectal submucosal invasive cancer after local resection: Japan Clinical Oncology Group Study JCOG1612 (RESCUE study)
    Kadota, Tomohiro
    Ikematsu, Hiroaki
    Sasaki, Takeshi
    Saito, Yutaka
    Ito, Masaaki
    Mizutani, Tomonori
    Ogawa, Gakuto
    Shitara, Kohei
    Ito, Yoshinori
    Kushima, Ryoji
    Kanemitsu, Yukihide
    Muto, Manabu
    BMJ OPEN, 2020, 10 (07):
  • [49] A prospective, single-center, single-arm clinical study of adjuvant toripalimab combined with axitinib in non-clear renal cell carcinoma (nccRCC) patients with high-risk recurrence factors (IUNU-RC-102).
    Liu, Guangxiang
    Zhang, Shun
    Qin, Haixiang
    Ji, Changwei
    Guo, Hongqian
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : TPS613 - TPS613
  • [50] Two-Year Results of the PHANTOM High Flex Trial: A Single-Arm Study on the Atlas Unicompartmental Knee System Load Absorber in Patients With Medial Compartment Osteoarthritis of the Knee
    Slynarski, Konrad
    Walawski, Jacek
    Smigielski, Robert
    van der Merwe, Willem
    CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2019, 12
12345